We are live on
!
Find out more
Macquarie Group Portfolio holdings
AUM
$23.2B
1-Year Est. Return
40.19%
This Fund
S&P 500
This Quarter
Est. Return
+2.46%
1 Year Est. Return
+40.19%
3 Year Est. Return
+109.35%
5 Year Est. Return
+140.11%
10 Year Est. Return
+481.97%
AUM
$59.3B
AUM Growth
+$673M
(+1.1%)
Cap. Flow
-$791M
Cap. Flow
% of AUM
-1.33%
Top 10 Holdings %
Top 10 Hldgs %
14.81%
Holding
1,919
New
237
Increased
675
Reduced
561
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DuPont de Nemours
DD
|
+$332M |
| 2 |
Occidental Petroleum
OXY
|
+$148M |
| 3 |
Halliburton
HAL
|
+$127M |
| 4 |
CVS Health
CVS
|
+$73.9M |
| 5 |
Western Alliance Bancorporation
WAL
|
+$70.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MIC
Macquarie Infrastructure Holdings, LLC
MIC
|
+$520M |
| 2 |
MMP
Magellan Midstream Partners, L.P.
MMP
|
+$194M |
| 3 |
RTX Corp
RTX
|
+$107M |
| 4 |
Waste Management
WM
|
+$102M |
| 5 |
Mondelez International
MDLZ
|
+$90M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 18.14% |
| 2 | Financials | 15.94% |
| 3 | Technology | 12.91% |
| 4 | Industrials | 9.34% |
| 5 | Energy | 8.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Toronto Dominion Bank
TD
$198B
| $7.38M | 0.01% |
126,371
+3,454
| +3% | +$194K |
|
677
Tandem Diabetes Care
TNDM
$1.21B
| $7.36M | 0.01% |
114,081
| – | – |
|
|
AZUL
678
DELISTED
Azul
AZUL
| $7.35M | 0.01% |
219,883
-102,793
| -32% | -$2.98M |
|
|
GRP.U
679
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $7.35M | 0.01% |
159,536
+91,836
| +136% | +$4.23M |
|
680
Eastman Chemical
EMN
$7.58B
| $7.28M | 0.01% |
93,482
-7,108
| -7% | -$540K |
|
681
Marriott International
MAR
$87B
| $7.27M | 0.01% |
51,801
-8,489
| -14% | -$1.13M |
|
682
Edwards Lifesciences
EW
$51.3B
| $7.18M | 0.01% |
116,529
-8,235
| -7% | -$498K |
|
683
iShares MSCI Emerging Markets ETF
EEM
$31.1B
| $7.05M | 0.01% |
203,641
+176,832
| +660% | +$7.51M |
|
684
Knight Transportation
KNX
$11B
| $6.99M | 0.01% |
212,779
+3,365
| +2% | +$107K |
|
|
ARQL
685
DELISTED
Arqule Inc
ARQL
| $6.94M | 0.01% |
630,000
+330,000
| +110% | +$2.3M |
|
686
AngloGold Ashanti
AU
$51.9B
| $6.93M | 0.01% |
389,223
-302
| -0.1% | -$4.05K |
|
|
SIVB
687
DELISTED
SVB Financial Group
SIVB
| $6.9M | 0.01% |
30,706
+4,973
| +19% | +$1.15M |
|
688
ManpowerGroup
MAN
$2.67B
| $6.87M | 0.01% |
71,090
+18,590
| +35% | +$1.69M |
|
689
West Pharmaceutical
WST
$25.9B
| $6.79M | 0.01% |
54,215
+603
| +1% | +$71.2K |
|
690
Mid-America Apartment Communities
MAA
$14.2B
| $6.75M | 0.01% |
57,309
+5,141
| +10% | +$579K |
|
691
New Oriental
EDU
$8.81B
| $6.74M | 0.01% |
69,797
-65,791
| -49% | -$5.89M |
|
|
WPX
692
DELISTED
WPX Energy, Inc.
WPX
| $6.69M | 0.01% |
581,137
+72,211
| +14% | +$898K |
|
693
Vornado Realty Trust
VNO
$6.54B
| $6.61M | 0.01% |
103,135
-70,541
| -41% | -$4.74M |
|
|
SGEN
694
DELISTED
Seagen Inc. Common Stock
SGEN
| $6.6M | 0.01% |
95,300
| – | – |
|
695
Acadia Pharmaceuticals
ACAD
$4.76B
| $6.59M | 0.01% |
246,376
+1,940
| +0.8% | +$49.6K |
|
696
DXC Technology
DXC
$1.84B
| $6.58M | 0.01% |
119,244
-177
| -0.1% | -$10.2K |
|
697
Moody's
MCO
$80.3B
| $6.55M | 0.01% |
33,560
-5,300
| -14% | -$1.01M |
|
698
Collegium Pharmaceutical
COLL
$722M
| $6.54M | 0.01% |
497,011
-1,914,707
| -79% | -$25.6M |
|
699
CoStar Group
CSGP
$12.2B
| $6.52M | 0.01% |
117,670
| – | – |
|
700
Amdocs
DOX
$6.37B
| $6.5M | 0.01% |
104,695
+35,620
| +52% | +$2.06M |
|
Similar funds
A
DSA
CLGM
BBHC
CB
AF
MG
Macquarie Group's Q2 2019 Portfolio in Review
As of Q2 2019, Macquarie Group held 1,919 positions worth $59.3B, up 1.1% from $58.6B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Macquarie Group's Q2 2019 filing shows 237 new, 675 increased, 561 reduced and 90 closed positions. Its largest new stake was Ferro Corporation: 2,403,865 shares worth $38M. The largest sale was Macquarie Infrastructure Holdings, LLC, an estimated $520M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 18% a quarter earlier, followed by Financials and Technology.
- Macquarie Group's largest Q2 2019 buy was Ferro Corporation: 2,403,865 shares worth $38M.
- Macquarie Group added most to DuPont de Nemours in Q2 2019, an estimated $332M increase.
- Macquarie Group's biggest Q2 2019 reduction was Macquarie Infrastructure Holdings, LLC, cutting an estimated $520M.
- Macquarie Group fully exited Steris in Q2 2019, selling an estimated $75.7M.
- Macquarie Group's ten largest holdings make up 15% of its $59.3B portfolio in Q2 2019.
- Macquarie Group opened 237 new positions and closed 90 in Q2 2019.
- Macquarie Group's portfolio value rose 1.1% quarter-over-quarter to $59.3B.
Based on Macquarie Group's 13F filing for Q2 2019, filed 14 Aug 2019.